Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on April 28, 2006

"This drug has been "de-risked", so to speak, because it has been under development for over ten years and had no safety issues in over 600 people.
So investors can get into a cycle of development that is near its end and that will appeal to them.
It means they can invest in a company that has a drug that could be very important to Australia, which is potentially not very far from getting approved."
In addition to the melanoma cancer vaccine, part of the funds will also be used to push the company's breast cancer vaccine into Phase 1 human trials.
Read the full report from The Age: Vaccinoma wants $17 million from IPO.
Permalink: Vaccinoma Hopes To Raise $17M from IPO
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/20913
Mr Wong
Vote for Vaccinoma Hopes To Raise $17M from IPO:
|
Rating: 6.67 out of 3 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







